Morgan Stanley maintains Cerner (NASDAQ:CERN) with a Equal-Weight and raises the price target from $85 to $95.
Wolfe Research Downgrades AbbVie to Peer Perform
Wolfe Research analyst Tim Anderson downgrades AbbVie (NYSE:ABBV) from Outperform to Peer Perform.